Stocktwits on MSN
SLS stock hits over 4-year high: CEO eyes FDA talks, ‘whole gamut’ of cancer uses for GPS
CEO Angelos Stergiou said survival in the Regal study appeared “unexpectedly long” and reiterated his bullish view on the probability of a successful outcome. ・Stergiou also outlined a potential FDA ...
GP fit notes declaring people unable to work will be replaced with support to help them stay in their job, under a government pilot scheme. GPs in two areas of England will refer patients for support ...
Stocktwits on MSN
SLS stock jumps premarket: CEO says GPS AML data has ‘very good chance’ to beat earlier survival outcomes
Stergiou said the delayed timeline for reaching the final event trigger has increased optimism for the Regal trial. ・The CEO also disclosed that some Regal patients remain on treatment more than three ...
South Korea's leading defense contractor, LIG Defense & Aerospace, and the state-backed Agency for Defense Development are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results